Effect of napabucasin and doxorubicin via the Jak2/Stat3 signaling pathway in suppressing the proliferation of neuroblastoma cells

Basit Öğe Kaydı
dc.authoridTuncer, Mehmet Cudi/0000-0001-7317-5467
dc.authoridunlu, ilker/0000-0003-4320-8381
dc.contributor.authorUnlu, Ilker
dc.contributor.authorTuncer, Mehmet Cudi
dc.contributor.authorOzdemir, Ilhan
dc.date.accessioned2025-02-22T14:08:47Z
dc.date.available2025-02-22T14:08:47Z
dc.date.issued2024
dc.departmentDicle Üniversitesien_US
dc.description.abstractPurpose: Napabucasin (NP) is a natural compound that can suppress cancer cell proliferation and cell cycle by inhibition of the signal transducer and activator of transcription 3 (STAT3) gene. We examined the effects of NP on the proliferation and invasion of neuroblastoma cells (SH-SY5Y). Methods: Human neuroblastoma SH-SY5Y cell line was used in this study. NP was administered to groups at the doses of 0.3-1 mu M. Cell viability was analyzed by MTT assay. Real-time quantitative reverse transcription polymerase chain reaction and western blot analysis assessed the expressions of interleukin (IL)-6 dependent Jak2/Stat3 signaling pathway. The MTT cell viability method was applied to determine the antagonistic-synergistic effects and inhibitory concentration (IC50) doses of doxorubicin (DX) and NP. Results: It was determined that 0.3-1 mu M doses of NP killed the cells almost completely after 48 hours, and also that Jak2/Stat3 expressions decreased dose-dependently via IL-6. At the protein level, NP and DX were found to reduce Jak2 and Stat3 levels. Conclusion: NP showed that it suppresses the proliferation of neuroblastoma cells. Due to its inhibitory effect on Jak2 and Stat3, it can be used to prevent invasion of SH-SY5Y cells. NP, which can inactivate Jak2/Stat3, can be used as a treatment agent by combining with DX in proliferation pathway in neuroblastoma.en_US
dc.identifier.doi10.1590/acb396624
dc.identifier.issn0102-8650
dc.identifier.issn1678-2674
dc.identifier.pmid39356934en_US
dc.identifier.scopus2-s2.0-85205526836en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.urihttps://doi.org/10.1590/acb396624
dc.identifier.urihttps://hdl.handle.net/11468/29636
dc.identifier.volume39en_US
dc.identifier.wosWOS:001328952300001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherActa Cirurgica Brasileiraen_US
dc.relation.ispartofActa Cirurgica Brasileiraen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmzKA_WOS_20250222
dc.subjectSTAT3 Transcription Factoren_US
dc.subjectCell Culture Techniquesen_US
dc.subjectCell Proliferationen_US
dc.subjectNeoplasmsen_US
dc.subjectBrainen_US
dc.titleEffect of napabucasin and doxorubicin via the Jak2/Stat3 signaling pathway in suppressing the proliferation of neuroblastoma cellsen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu